JP2024502821A5 - - Google Patents
Info
- Publication number
- JP2024502821A5 JP2024502821A5 JP2023540497A JP2023540497A JP2024502821A5 JP 2024502821 A5 JP2024502821 A5 JP 2024502821A5 JP 2023540497 A JP2023540497 A JP 2023540497A JP 2023540497 A JP2023540497 A JP 2023540497A JP 2024502821 A5 JP2024502821 A5 JP 2024502821A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- compound
- solvate
- hydrate
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063133160P | 2020-12-31 | 2020-12-31 | |
| US63/133,160 | 2020-12-31 | ||
| PCT/US2021/065777 WO2022147318A1 (en) | 2020-12-31 | 2021-12-30 | Methods of treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502821A JP2024502821A (ja) | 2024-01-23 |
| JP2024502821A5 true JP2024502821A5 (cg-RX-API-DMAC7.html) | 2024-12-24 |
Family
ID=82260959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023540497A Pending JP2024502821A (ja) | 2020-12-31 | 2021-12-30 | 処置方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240058350A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4271375A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024502821A (cg-RX-API-DMAC7.html) |
| AR (1) | AR124542A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202241446A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022147318A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018336787B2 (en) | 2017-09-19 | 2024-05-30 | Corflow Therapeutics Ag | Intracoronary characterization of microvascular obstruction (MVO) and myocardial infarction |
| EP4792852A2 (en) | 2020-05-22 | 2026-08-19 | CorFlow Therapeutics AG | Controlled flow infusion microvascular dysfunction diagnostic and therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20061130A1 (es) * | 2004-11-19 | 2007-01-05 | Arena Pharm Inc | Derivados de 3-fenil-pirazol como moduladores del receptor de serotonina 5-ht2a |
| EP2027119A2 (en) * | 2006-05-18 | 2009-02-25 | Arena Pharmaceuticals, Inc. | Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| US8084475B2 (en) * | 2009-12-04 | 2011-12-27 | Intermune, Inc. | Pirfenidone therapy and inducers of cytochrome P450 |
| US8980891B2 (en) * | 2009-12-18 | 2015-03-17 | Arena Pharmaceuticals, Inc. | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto |
| AU2012221704B2 (en) * | 2011-02-23 | 2013-12-05 | Coeruleus Ltd. | Flumazenil complexes, compositions comprising same and uses thereof |
| US20140314676A1 (en) * | 2011-11-18 | 2014-10-23 | Apotex Technologies Inc. | Methods of treatment with deferiprone |
| TR201905773T4 (tr) * | 2013-10-01 | 2019-05-21 | Sphingotec Gmbh | Bir majör advers kardiyak olayla karşılaşma riskinin tahmin edilmesi için bir usul. |
| US20160324897A1 (en) * | 2014-01-17 | 2016-11-10 | President And Fellows Of Harvard College | Platelet decoys and use thereof |
-
2021
- 2021-12-30 JP JP2023540497A patent/JP2024502821A/ja active Pending
- 2021-12-30 TW TW110149645A patent/TW202241446A/zh unknown
- 2021-12-30 AR ARP210103706A patent/AR124542A1/es unknown
- 2021-12-30 EP EP21916534.7A patent/EP4271375A4/en active Pending
- 2021-12-30 US US18/259,843 patent/US20240058350A1/en active Pending
- 2021-12-30 WO PCT/US2021/065777 patent/WO2022147318A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5792059B2 (ja) | 抗血小板療法中の血小板抑制のメンテナンス | |
| AU2016243700A1 (en) | Compositions and methods for treating anemia | |
| EA015122B1 (ru) | Фармацевтическая композиция и ее применение для лечения тромбоза | |
| CN115461072A (zh) | 用于治疗非酒精性脂肪性肝炎的司美格鲁肽 | |
| JP7569492B2 (ja) | 抗精神病薬誘発性体重増加のミリコリラントによる治療方法 | |
| US20250073227A1 (en) | Prevention and/or treatment of contrast-induced acute kidney injury | |
| JP5837877B2 (ja) | 静脈内投与イブプロフェンを用いた患者の治療 | |
| BR112020007817A2 (pt) | método de uso e composições contendo dulaglutido | |
| JP2005516050A (ja) | 急性心筋梗塞のための複合治療 | |
| JP2024503377A (ja) | バダデュスタットを使用した治療方法 | |
| EP4271375A1 (en) | Methods of treatment | |
| Hogan et al. | Chronic administration of N‐acetylcysteine fails to prevent nitrate tolerance in patients with stable angina pectoris. | |
| AU2022224562A1 (en) | Therapeutic methods | |
| KR101952805B1 (ko) | 혈관차단제를 포함하는 간암 치료용 조성물 | |
| TW202302097A (zh) | 伐達司他之藥物－藥物交互作用的調節 | |
| WO2022004867A1 (ja) | 排尿症状治療剤 | |
| JP6420923B1 (ja) | 医薬 | |
| CN104507478A (zh) | 用于治疗急性冠状动脉综合征的烟酰胺衍生物 | |
| JP6894555B1 (ja) | 排尿症状治療剤 | |
| CA2981176C (en) | Compositions and methods for treating anemia | |
| Croasdell | Digestive Disease Week 2017. Chicago, Illinois, USA-May 6-9, 2017 | |
| HK1168734A (en) | Treating patients with intravenous ibuprofen | |
| JPS6148482B2 (cg-RX-API-DMAC7.html) |